Harnessing grid computing to save women's lives

Breast cancer is the most common cancer in women. In the EU and the US, one in eight will develop it at some point in their lives, and it will kill one in 28. But harnessing the power of the grid could help increase the accuracy of diagnoses.

Mammography examinations save thousands of women's lives every year. However the rate of misdiagnosis can be high – in some instances up to 30%. This is due in part to physical differences across patient populations, differences in equipment and procedures, and difficulty in using computers to help detect changes in breast tissue.

Computer-aided detection of this potentially fatal cancer, especially when used together with the traditional method of visually screening mammograms, can not only shorten the time needed for analysis, but can also help increase the accuracy of diagnoses.

Novel approach to comparative diagnoses
The team in the European IST project MammoGrid, which ended in August 2005, aimed to apply the power of the grid to see if they could more accurately detect breast cancer. The prototype software that resulted is already enabling users – hospitals, doctors, clinicians, radiologists and researchers – to harness the massive capacity of grid computing to run advanced algorithms on digital mammograms, stored Europe-wide.

The project team also developed a geographically distributed, grid-based database of standardised images and associated patient data. Already, there are 30,000 images stored from over 3,000 patients, equally balanced between the University Hospital of Cambridge in the UK and Udine in Italy.

The novelty of the MammoGrid approach lies in the application of grid technologies to medical diagnoses, and in providing the data and tools to enable users to compare new mammograms with existing ones in the grid database. Users can access mammograms from a variety of sources, and also computer-aided detection algorithms to detect micro-calcifications (tiny specks of calcium in the breast that could indicate cancer) and monitor breast density (dense tissue is considered a major risk factor).

Sharing resources and patient data
"The system in its current version allows users to securely share both resources and patient data which has been treated to ensure anonymity," explains project coordinator David Manset of Maat GKnowledge in Madrid, Spain. "It also supports effective co-working and provides the means for powerful comparative analyses through the use of a standard format for mammogram images".

This break-through functionality could lead to major advances in prevention and detection of the disease. It also opens the door to novel, broad-based statistical analyses of the incidence of breast cancer and its different forms.

MammoGrid+ building on the achievements
Since the project ended, a new consortium independent of IST funding has been set up to further develop the prototype and take it closer to market needs. Under Mammogrid+, a new set of partners (including organisations such as CIEMAT (Spain's Energy, Environmental and Technological Research Centre), CERN (Switzerland), SES (health service for the Extremadura region of Spain, representing the hospitals of Infanta Christina, Don Benito and Merida), and the university hospitals of Cambridge and Udine) is building on the results already achieved.

The new project team has set up four separate sites, to simulate the needs of four different hospitals and test the latest project developments. The results from these tests have been evaluated by a panel of two IT experts and five clinicians from the hospitals in Spain’s Extremadura region.

Their feedback is being incorporated into a pre-commercial release of the software (Mammogrid+ version 1.0) in June 2007. This version is being deployed within the five hospitals collaborating in the project – these hospitals will also receive the hardware infrastructure to host the Mammogrid+ suite.

Future plans include broadening the existing database Europe-wide. Already a further hospital, the university hospital of Cork in Ireland, has shown interest in joining the Mammogrid+ network.

"The inclusion of the new hospitals will increase the coverage of the database and make our knowledge more relevant and more accurate," Manset concludes. "This will allow larger and more refined epidemiological studies. In the end, these techniques could help save lives."

Contact:
David Manset
Maat GKnowledge
Calle San Bernardo num 115, 5 izq
E-28015 Madrid
Spain
Tel: +34 68 780 2661
Fax: +34 67 347 9175
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Source: IST Results Portal

For further information, please visit:
www.mammogrid.com

Most Popular Now

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

AI Tool that may Assist Underserved Hosp…

As the fields of healthcare and technology increasingly evolve and intersect, researchers are collaborating on the best ways to use emerging technologies such as artificial intelligence (AI) to care for...

AI Model Identifies Potential Risk Genes…

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can...

AI-Supported Breast Cancer Screening - N…

The new findings are published in The Lancet Digital Health. The initial results of the Mammography Screening with Artificial Intelligence (MASAI) study* - a randomised trial to evaluate whether AI...

AI Improves Personalized Cancer Treatmen…

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease. However, these...

The Future of Healthcare is Digital

8 - 10 April 2025, Berlin, Germany. The Berlin Exhibition Centre will be all about digital health from 8 to 10 April 2025. DMEA, Europe's leading event for digital healthcare, organised...

DMEA nova Award: Looking for the Best Id…

8 - 10 April 2025, Berlin, Germany. Innovative startups from the digital health sector can now apply for the DMEA nova Award 2025. We are looking for the best idea or...

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...